ANTONIO RAFAEL
CÁLIZ CÁLIZ
PROFESOR CONTRATADO DOCTOR
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (10)
2023
-
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Reumatologia Clinica, Vol. 19, Núm. 10, pp. 533-548
2019
-
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 102-108
2017
2014
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
2009
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
Arthritis Research and Therapy, Vol. 11, Núm. 2
-
Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583
-
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA
Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595
-
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors
Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564
2008
-
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274
2006
-
Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period
Arthritis Research and Therapy, Vol. 8, Núm. 1